Anthony Petrone
Stock Analyst at Mizuho
(4.04)
# 526
Out of 5,132 analysts
214
Total ratings
54.14%
Success rate
10.96%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Outperform | $130 → $85 | $59.65 | +42.50% | 8 | Feb 12, 2026 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $80 | $57.64 | +38.79% | 17 | Feb 6, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $140 → $115 | $74.12 | +55.15% | 9 | Feb 5, 2026 | |
| EXAS Exact Sciences | Downgrades: Neutral | $85 → $105 | $103.23 | +1.71% | 2 | Jan 20, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $18 → $21 | $18.69 | +12.36% | 2 | Dec 17, 2025 | |
| MDXG MiMedx Group | Maintains: Outperform | $12 → $10 | $5.09 | +96.46% | 5 | Dec 17, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $70 → $72 | $63.91 | +12.66% | 10 | Dec 17, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $60 → $72 | $68.72 | +4.77% | 7 | Dec 17, 2025 | |
| GH Guardant Health | Maintains: Outperform | $100 → $120 | $102.76 | +16.78% | 4 | Dec 17, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Outperform | $85 → $90 | $73.54 | +22.38% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $78 | $65.08 | +19.85% | 3 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $100 | $81.70 | +22.40% | 16 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $32.61 | +22.66% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $100 | $78.55 | +27.31% | 11 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $300 | $245.73 | +22.09% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $100 | $76.44 | +30.82% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $70 → $78 | $74.91 | +4.12% | 10 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $135 | $104.54 | +29.14% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $111.47 | +21.11% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $16.49 | +9.16% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $100.88 | -0.87% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $10.00 | +20.00% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $106.74 | +63.95% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $7.58 | +427.70% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $63.25 | -8.30% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $15.59 | -10.20% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $78.65 | +33.50% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $478.60 | -18.51% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $86.60 | -22.63% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $95.18 | +83.86% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $13.38 | +86.85% | 3 | May 13, 2020 |
Inspire Medical Systems
Feb 12, 2026
Maintains: Outperform
Price Target: $130 → $85
Current: $59.65
Upside: +42.50%
Haemonetics
Feb 6, 2026
Maintains: Outperform
Price Target: $90 → $80
Current: $57.64
Upside: +38.79%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $140 → $115
Current: $74.12
Upside: +55.15%
Exact Sciences
Jan 20, 2026
Downgrades: Neutral
Price Target: $85 → $105
Current: $103.23
Upside: +1.71%
Tandem Diabetes Care
Dec 17, 2025
Maintains: Neutral
Price Target: $18 → $21
Current: $18.69
Upside: +12.36%
MiMedx Group
Dec 17, 2025
Maintains: Outperform
Price Target: $12 → $10
Current: $5.09
Upside: +96.46%
LivaNova
Dec 17, 2025
Maintains: Outperform
Price Target: $70 → $72
Current: $63.91
Upside: +12.66%
Lantheus Holdings
Dec 17, 2025
Maintains: Outperform
Price Target: $60 → $72
Current: $68.72
Upside: +4.77%
Guardant Health
Dec 17, 2025
Maintains: Outperform
Price Target: $100 → $120
Current: $102.76
Upside: +16.78%
Establishment Labs Holdings
Dec 17, 2025
Maintains: Outperform
Price Target: $85 → $90
Current: $73.54
Upside: +22.38%
Dec 17, 2025
Maintains: Outperform
Price Target: $75 → $78
Current: $65.08
Upside: +19.85%
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $100
Current: $81.70
Upside: +22.40%
Dec 1, 2025
Initiates: Outperform
Price Target: $40
Current: $32.61
Upside: +22.66%
Nov 11, 2025
Maintains: Outperform
Price Target: $110 → $100
Current: $78.55
Upside: +27.31%
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $245.73
Upside: +22.09%
Oct 31, 2025
Maintains: Outperform
Price Target: $90 → $100
Current: $76.44
Upside: +30.82%
Oct 23, 2025
Downgrades: Neutral
Price Target: $70 → $78
Current: $74.91
Upside: +4.12%
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $104.54
Upside: +29.14%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $111.47
Upside: +21.11%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $16.49
Upside: +9.16%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $100.88
Upside: -0.87%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $10.00
Upside: +20.00%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $106.74
Upside: +63.95%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $7.58
Upside: +427.70%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $63.25
Upside: -8.30%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $15.59
Upside: -10.20%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $78.65
Upside: +33.50%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $478.60
Upside: -18.51%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $86.60
Upside: -22.63%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $95.18
Upside: +83.86%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $13.38
Upside: +86.85%